Cours ROCHE HOLDING BJ Euronext Paris
Actions
MLROH
CH0012032048
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- | - |
|
CA 2024 * | 60,47 Md 67,64 Md 0 | CA 2025 * | 63,84 Md 71,41 Md 0 | Capitalisation | 209 Md 234 Md 0 |
---|---|---|---|---|---|
Résultat net 2024 * | 13,43 Md 15,02 Md - | Résultat net 2025 * | 14,85 Md 16,61 Md - | VE / CA 2024 * | 3,69 x |
Dette nette 2024 * | 14,28 Md 15,97 Md 0 | Dette nette 2025 * | 9,19 Md 10,28 Md 0 | VE / CA 2025 * | 3,42 x |
PER 2024 * |
15,1
x | PER 2025 * |
13,8
x | Employés | - |
Rendement 2024 * |
3,78% | Rendement 2025 * |
3,88% | Flottant | 88,91% |
Dernier transcript sur ROCHE HOLDING BJ
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 49 | 01/01/03 | |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/04/11 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/01/96 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
BELLATRIX C | Non | 2.88M EUR | +7,00% | |
BL-GLOBAL EQUITIES B EUR | Non | 5.75M EUR | +16,00% | |
BL-GLOBAL 75 A EUR | Non | 26.25M EUR | +4,00% | |
BELFIUS EQUITIES GLOB HEALTH CARE C$ CAP | Non | 3.63M USD | -3,00% | |
AXAWF DYNAMIC OPTIMAL INCOME I CAP USD | Non | 0.97M USD | +1,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+61,53% | 848 Md | |
+38,95% | 627 Md | |
-3,66% | 363 Md | |
+15,06% | 318 Md | |
+9,18% | 299 Md | |
+16,53% | 225 Md | |
+15,67% | 179 Md | |
+2,47% | 167 Md | |
+2,41% | 125 Md |
- Bourse
- Actions
- Action ROG
- Action MLROH